Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.

NARecruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

May 9, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
Diabetic Foot Ulcer
Interventions
OTHER

Dual-layer perinatal tissue allograft

The dual-layer perinatal tissue allograft is an amnion - amnion allograft

OTHER

Three-layer fenestrated perinatal tissue allograft

The three-layer fenestrated perinatal tissue allograft is an amnion - chorion - amnion allograft

OTHER

Standard of care

Standard of care (SOC) will include cleansing of the index wound with sterile normal saline solution, followed by sharp debridement to remove necrotic tissue, application of appropriate dressings and wound off-loading.

Trial Locations (1)

28112

RECRUITING

Monroe Biomedical Research, Monroe

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Serena Group

OTHER

lead

Samaritan Biologics

INDUSTRY

NCT06437028 - Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers. | Biotech Hunter | Biotech Hunter